Page 23 - index
P. 23
Clinical study III: Improved skin surface in cellulite
Designed to investigate the ability of VERISOL to treat cellulite in normal and overweight women.
®
Study Design Results
// Double-blind, placebo-controlled trial // Significantly decreased skin waviness
• Overall VERISOL group: -8%
®
// 105 women aged 24-50, two subgroups • Subgroup of women of normal weight
(BMI < 25 and > 25) (BMI < 25): -11%
// Daily intake of 2,5g VERISOL vs. placebo // Significant higher dermal density after 6
®
// Duration: 6 months months vs. placebo
Schunck et al. (2015). Dietary Supplementation with Specific Collagen Peptides has a
Body Mass Index-Dependent Beneficial Effect on Cellulite Morphology. J Med Food,
18:1340–1348.
Reduced waviness of the skin surface profile
Improvement of dermal
Epidermis density and connective
tissue, leading to reduced
Dermis with waviness
collagen-fibers
Connective
tissue fibers
Subcutis
Normal Skin Skin with Cellulite Effects of QYRA ®
CLINICAL STUDIES | 23

